Riccardo Pagani

Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses

L. Naldini, A. Mucci, F. Sanvito, 2021, EMBO molecular medicine.

miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease

M. Valsecchi, Paola Capasso, D. Silvestri, 2023, Leukemia.